Aripiprazole as the Causative Agent of Neuroleptic Malignant Syndrome

View This PDF

NB: This article is only available as a PDF.

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Neuroleptic malignant syndrome (NMS) is a rare and potentially life-threatening neurologic emergency commonly associated with the use of antipsychotic medications. As a class, atypical antipsychotic agents have lower associated rates of extrapyramidal symptoms and are less likely to induce NMS as compared to conventional antipsychotics. One of the newest agents in the atypical antipsychotic class is aripiprazole

Prim Care Companion J Clin Psychiatry 2007;9(2):148-150 [letter]

https://doi.org/10.4088/PCC.v09n0211b